Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in United States
274 trials · From ClinicalTrials.gov, checked 19 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Aurora, Baltimore, Boston, Duarte, Grand Rapids, Houston, Irving, Kansas City, Nashville, Orlando, Phoenix, Rochester, Salt Lake City, San Antonio, Scottsdale, West Valley City
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - Phase 2Taking peopleOlanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
- Where
- Portland
- Age
- 18 years and over
- People
- 66
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT05705492 - Phase 1Taking peopleA Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Where
- Atlanta, Aurora, Austin, Detroit, Duarte, Fairfax, Greenville, Lake Success, Las Vegas, Nashville, New Orleans, New York, Norfolk, Pittsburgh, Salt Lake City, San Antonio, Santa Fe, Tucson, West Valley City
- Age
- 18 years and over
- People
- 154 worldwide
- Run by
- Coherus Oncology, Inc.
See details and how to joinNCT06657144 - Phase 2Taking peopleRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Where
- Orange
- Age
- 18 years and over
- People
- 75
- Run by
- University of California, Irvine
See details and how to joinNCT06580002 - No phaseTaking peopleA Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- Where
- Duarte
- Age
- 18 years and over
- People
- 1,000
- Run by
- City of Hope Medical Center
See details and how to joinNCT07224750 - No phaseTaking peopleIntegrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma
- Where
- Monrovia
- Age
- 18 years and over
- People
- 600
- Run by
- City of Hope Medical Center
See details and how to joinNCT07266363 - No phaseNot yet taking people in United StatesA Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 72
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT07517211 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Anaheim, Anchorage, Babylon, Bonney Lake, Boston, Brooklyn, Calumet City, Chicago, Cleveland, Coon Rapids, Crown Point, Edmonds, Fairfax, Fairway, Fayetteville, Federal Way, Flossmoor, Fort Myers, Fort Wayne, Fullerton, Gig Harbor, Harvey, Hollywood, Houston, Indianapolis, Irving, Kansas City, Las Vegas, Los Alamitos, Los Angeles, Minneapolis, Nashville, New Hyde Park, New Lenox, Newton, New York, Oklahoma City, Olympia, Orlando, Orland Park, Overland Park, Patchogue, Pearland, Pembroke Pines, Port Jefferson Station, Portland, Puyallup, Riverhead, Rogers, Saint Paul, San Antonio, Santa Monica, Seattle, Shirley, Sioux Falls, Springdale, Springfield, Tacoma, The Bronx, Tinley Park, Torrance, Tyler, Webster, Westwood
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - No phaseTaking peopleDetection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers
- Where
- Duarte
- Age
- 18 years and over
- People
- 500
- Run by
- City of Hope Medical Center
See details and how to joinNCT07243015 - Phase 4Taking peoplePharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 22
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT05183126 - Phase 2Enrolling by invitationHyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence
- Where
- Rochester
- Age
- 18 years to 80 years
- People
- 16
- Run by
- Mayo Clinic
See details and how to joinNCT07139951 - No phaseTaking peopleClonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Where
- Boston
- Age
- 18 years and over
- People
- 5,000
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07675967 - No phaseTaking peopleIntegrated Cancer Repository for Cancer Research
- Where
- Aitkin, Alliance, Aurora, Bozeman, Brainerd, Canton, Council Bluffs, Daytona Beach, DeLand, Duluth, Fargo, Fayetteville, Fergus Falls, Fort Wayne, Glens Falls, Green Bay, Greenwood Village, Hastings, Holyoke, Kansas City, Liberty, Manchester, Minot, Norfolk, North Kansas City, North Platte, Omaha, Orange City, Overland Park, Palm Coast, Randallstown, Saint Joseph, Tallahassee, Utica, Waterloo, Westminster, Yorkville
- Age
- 19 years to 110 years
- People
- 999,999
- Run by
- University of Nebraska
See details and how to joinNCT02012699 - No phaseEnrolling by invitationUniversity of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 1,000
- Run by
- University of North Carolina, Chapel Hill
See details and how to joinNCT02427269 - No phaseNot yet taking people in United StatesMinimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial
- Where
- Eau Claire, Rochester, Scottsdale
- Age
- 18 years to 85 years
- People
- 1,010
- Run by
- Mayo Clinic
See details and how to joinNCT07206589 - Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Austin, Chicago, Duarte, Durham, Fairfax, Fort Wayne, Grand Rapids, Houston, Huntersville, Indianapolis, Irvine, Irving, Los Angeles, Louisville, Minneapolis, Omaha, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - No phaseTaking peopleIndividualized Dose Escalation of 5-FU for Gastrointestinal Cancer
- Where
- Lebanon
- Age
- 18 years and over
- People
- 36
- Run by
- Dartmouth-Hitchcock Medical Center
See details and how to joinNCT05780684 - Phase 2/3Not yet taking people in United StatesStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Where
- Grand Rapids
- Age
- 18 years and over
- People
- 175 worldwide
- Run by
- GE Healthcare
See details and how to joinNCT07219238 · EU 2024-519384-18-00 - Phase 1Taking peopleBAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Ann Arbor, Atlanta, Coral Gables, Dallas, Houston, New Haven, New York, Portland, The Bronx
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- SillaJen, Inc.
See details and how to joinNCT05768932 - No phaseTaking peopleData Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- Where
- Houston
- Age
- 18 years and over
- People
- 5,000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT00991094 - Phase 1Taking peopleFirst-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Where
- Boston, Cleveland, Duarte, Durham, Fairfax, New York, Orange, San Antonio, Scottsdale, St Louis
- Age
- 18 years and over
- People
- 155
- Run by
- Plexium, Inc.
See details and how to joinNCT07284186 - Phase 2Taking peopleAvapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
- Where
- Houston
- Age
- 18 years and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04771520 - Phase 1Taking peopleA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Where
- Beverly Hills, Houston, Santa Monica
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Epkin
See details and how to joinNCT06789172 - Phase 1Enrolling by invitationA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
- Where
- Grand Rapids, Houston, Huntersville, Myrtle Beach, Nashville, New Haven, New York, San Antonio, San Francisco, Seattle, West Valley City
- Age
- 18 years and over
- People
- 149
- Run by
- Rondo Therapeutics
See details and how to joinNCT07218003 - Phase 1Taking peopleDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- Where
- Fort Worth, Los Angeles, West Valley City
- Age
- 18 years and over
- People
- 40
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT07517198